Race Oncology Ltd.

Race Oncology Ltd.
Stock Exchange Australian Stock Exchange
EPS
AUD0.07
Market Cap
AUD4.11 M
Shares Outstanding
82.24 M
Public Float
65.63 M

Profile

Address
710 Collins Street
Docklands Victoria (VIC) 3008
Australia
Employees -
Website http://www.raceoncology.com
Updated 07/08/2019
Race Oncology Ltd is a pharmaceutical company, whose business model is to pursue later stage drug assets, principally in the cancer field. Its first important asset is a chemotherapy drug, called Bisantrene, which is used as the first line of treatment for Acute Myeloid Leukaemia and many other cancers. The company was founded on February 15, 2011 and is headquartered in Docklands, Australia.

Financials

View All

William J. Garner
Chairman
Peter Laurence Molloy
Chief Executive Officer, Director & MD